{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-013641","form_type":"8-K","ticker":"NRC","cik":"0000070487","company_name":"NRC HEALTH","filed_at":"2026-04-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.654384+00:00","generated_at":"2026-05-15T03:24:36.652862+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NRC Health Q1 revenue up 4% to $34.8M; TRCV record $152.1M (+13% YoY)","bullets":["GAAP net income $3.2M ($0.14 diluted EPS); adjusted net income $4.6M ($0.21 adjusted diluted EPS).","Adjusted EBITDA $9.4M (27% of revenue); cash flow from operations $7.2M up 8% YoY.","Total Recurring Contract Value (TRCV) $152.1M, up 13% YoY, sixth consecutive quarterly increase.","Company signed the largest deal in its 45-year history; new sales and retention reached multi-year highs.","Free cash flow $5.4M (15% of revenue); revenue $34.8M, first YoY growth since 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-013641","json":"https://secwatch.observer/filing/0001437749-26-013641.json","markdown":"https://secwatch.observer/filing/0001437749-26-013641.md","text":"https://secwatch.observer/filing/0001437749-26-013641.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70487/000143774926013641/0001437749-26-013641-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70487/000143774926013641/nrc20260424_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T03:24:36.652862+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"118f6cbf4314f715ad668e653d99b9904ae74307","claim":"NRC HEALTH reported first quarter ended March 31, 2026 results: revenue $34.8 million, net income $3.2 million, EPS $0.14.","evidence_excerpt":"outcomes driver, helping healthcare organizations turn Human Understanding into measurable, repeatable improvement.\" First Quarter 2026 Highlights ● Revenue: Total revenue was $34.8 million for the three months ended March 31, 2026, up 4% from the prior year ● Net Income : GAAP net income was $3.2 million, representing 9% of revenue, and Adjusted Net Income* was","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/70487/000143774926013641/0001437749-26-013641-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2026"},{"label":"Revenue","value":"$34.8 million"},{"label":"Net income","value":"$3.2 million"},{"label":"EPS","value":"$0.14"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}